Antibodies Against Cytomegalovirus Infection in Pregnancy with Recurrent Miscarriage
DOI:
https://doi.org/10.56056/Keywords:
Cytomegalovirus infection, IgG, IgM, Miscarriage recurrenceAbstract
Background and objectives: Recurrent pregnancy loss leads to serious obstetrical and psychosocial consequences specifically if causes are unknown. The aim of this study is to evaluate the role of cytomegalovirus infection in women with recurrent pregnancy loss.
Methods: This is a case-control study implemented in outpatient's clinic of Maternity hospital in Erbil city over duration of one year from 1st of June, 2022 to 31st of May, 2023 included 100 women with miscarriages recurrences and 100 women without history of miscarriage. A sample of 5 ml blood was drawn from selected women and sent for investigation. Serologically, cytomegalovirus infection was confirmed through recording cytomegalovirus immunoglobulin-G and immunoglobulin-M anti-bodies detection in private laboratory.
Results: The age, body mass index, educational level, occupation, residence and parity history of study participants were not statistically different between study groups (p>0.05). The consanguinity was statistically related to controls (40%) and the positive family history of repeated pregnancy loss was statistically related to women with repeated pregnancy loss (12%) (p?0.05). Cytomegalovirus immunoglobulin M seropositivity was not statistically different between study groups (2% versus 2%) (p>0.05), however, cytomegalovirus immunoglobulin G seropositivity was prevalent in women with recurrent pregnancy loss (100%) (p=0.04).
Conclusions: The cytomegalovirus infection is a risk factor for miscarriages recurrence.
Downloads
References
1. Atik RB, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S Et al. ESHRE guideline: recurrent pregnancy loss Hum Reprod Open 2018 Apr 6;2018(2):hoy004. doi: 10.1093/hropen/hoy004. eCollection 2018.
2. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-1111. doi: 10.1016/j.fertnstert.2012.06.048.
3. Deng T, Liao X, Zhu S. Recent Advances in Treatment of Recurrent Spontaneous Abortion. Obstet Gynecol Surv. 2022;77(6):355-366. doi: 10.1097/OGX.0000000000001033/
4. Royal College of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG. 2011; 17:1-7.
5. Kolte AM, Bernardi LA, Christiansen OB, Quenby S, Farquharson RG, Goddijn M, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30(3):495-498. doi: 10.1093/humrep/deu299/
6. Jeve YB, Davies W. Evidence-based management of recurrent miscarriages. J Hum Reprod Sci. 2014 Jul;7(3):159-69. doi: 10.4103/0974-1208.142475/
7. Ministry of Health (Iraq), Central Organization for Statistics and Information Technology (Iraq), Kurdistan Regional Statistics Office, World Health Organization (WHO), Ministry of Health (Kurdistan). Iraq Family Health Survey 2006-2007. Available from:https://reliefweb.int/report/iraq/iraq-family-health-survey-20067/
8. Abdollahi E, Tavasolian F, Ghasemi N, Mirghanizadeh SA, Azizi M, Ghoryani M, et al. Association between lower frequency of R381Q variant (rs11209026) in IL-23 receptor gene and increased risk of recurrent spontaneous abortion (RSA). J Immunotoxicol. 2015;12(4):317-321. doi: 10.3109/1547691x.2014.978056/
9. Turocy JM, Rackow BW. Uterine factor in recurrent pregnancy loss. Semin Perinatol. 2019;43(2):74-79. doi: 10.1053/j.semperi.2018.12.003/
10. Hodinka RL. Human cytomegalovirus. In: Jorgensen JH, Carroll KC, Funke G, Pfaller MA, Landry ML, Ritcher SS, Warnock DW eds. Manual of clinical microbiology. 11th ed. Wiley; 2015:1718-1737.https://doi.org/10.1128/9781555817381.ch100/
11. Sherkat R, Meidani M, Zarabian H, Rezaei A, Gholamrezaei A. Seropositivity of cytomegalovirus in patients with recurrent pregnancy loss. J Res Med Sci. 2014;19(Suppl 1):S22-25.
12. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102. doi: 10.1128/CMR.00062-12/
13. Pass RF, Anderson B. Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection. J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1(Suppl 1):S2-6. doi: 10.1093/jpids/piu069/
14. Yeroh MI, Aminu M, Musa BO. Seroprevalence of cytomegalovirus infection amongst pregnant women in Kaduna state, Nigeria. AJOL. 2015;16(1):37-44.https://doi.org/10.4314/ajcem.v16i1.7/
15. Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol. 2011;2011:1-9.https://doi.org/10.1155%2F2011%2F942937/
16. Nigro G, Adler SP. Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecol. 2011;23(2):123-128https://doi.org/10.1097/gco.0b013e328342f1f6/
17. Akunaeziri UA, Magaji AF, Anyaka C, Ocheke AN. Cytomegalovirus infection among women with recurrent miscarriages. Trop J Obstet Gynaecol. 2021;38(2):128-138.
18. Ali KS. The Sero-Prevalence of Cytomegalovirus Infection among Women with Abortion and Intrauterine Death in Erbil City Kurdistan Region, Iraq. Diyala J Med. 2020;18(1):77-90.
19. Yalda KF, Goreal AA. Prevalence of Cytomegalovirus Infection Among Pregnant Women with Cord Blood Examination. J Contemp Med Sci. 2023;9(1):35-39 https://doi.org/10.22317/jcms.v9i1.1315/
20. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63. https://doi.org/10.1016/j.fertnstert.2019.11.025/
21. Nitu R, Neamtu R, Iordache O, Stelea L, Dahma G, Sacarin G, et al. A Cross-Sectional Analysis of Intimacy Problems, Stress Levels, and Couple Satisfaction among Women with Thrombophilia Affected by Recurrent Pregnancy Loss. Int J Environ Res Public Health. 2023;20(2):1208.http://dx.doi.org/10.3390/ijerph20021208/
22. Gowri V, Udayakumar AM, Bsiso W, Al Farsi Y, Rao K. Recurrent early pregnancy loss and consanguinity in Omani couples. Acta Obstet Gynecol Scand. 2011;90(10):1167-1169.https://doi.org/10.1111/j.1600-0412.2011.01200.x/
23. Abdulrahman IJ, Jawad AK, Amin NA. Recurrent pregnancy loss at gynecology and obstetrical hospital in Duhok Province. Int J Res Med Sci. 2020;8(9):3160-164 http://dx.doi.org/10.18203/2320-6012.ijrms20203511/
24. Eleje GU, Ugwu EO, Igbodike EP, Malachy DE, Nwankwo EU, Ugboaja JO, et al. Prevalence and associated factors of recurrent pregnancy loss in Nigeria according to different national and international criteria (ASRM/ESHRE vs. WHO/RCOG). Front. reprod. health. 2023; 5:1049711.https://doi.org/10.3389%2Ffrph.2023.1049711/
25. Islam MA, Sharmin F, Hasan M. Seroprevalence of Cytomegalovirus Infection Among Pregnant Women with Prior Miscarriages in Dhaka, Bangladesh. Eurasian J Med. 2023;18(22):101.
26. Aljumaili ZK, Alsamarai AM, Najem WS. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq. J Infect Public Health. 2014;7(4):277-288.https://doi.org/10.1016/j.jiph.2013.08.006/
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Nashmel Farhad Mamand, Ariana Khalis Jawad
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
